Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine nasal spray for opioid-free anesthesia in digestive endoscopy
ChiCTR2600133886Phase 4Completed
- Sponsor
- Qinghai Provincial People's Hospital
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine, alfentanil and propofol in gastrointestinal conditions (3 arms), sponsored by Qinghai Provincial People's Hospital. Primary endpoints: Anxiety score, Non-invasive blood pressure and 3 more. Started May 2025; status: completed.
02
Drugs
dexmedetomidinealfentanilpropofol
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on ChiCTR2600133886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600133886.